BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15819717)

  • 1. Aberrant methylations in cancer cells: where do they come from?
    Ushijima T; Okochi-Takada E
    Cancer Sci; 2005 Apr; 96(4):206-11. PubMed ID: 15819717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
    Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
    Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae.
    Enomoto S; Maekita T; Tsukamoto T; Nakajima T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
    Cancer Sci; 2007 Dec; 98(12):1853-61. PubMed ID: 17900260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased fidelity in replicating DNA methylation patterns in cancer cells leads to dense methylation of a CpG island.
    Watanabe N; Okochi-Takada E; Yagi Y; Furuta JI; Ushijima T
    Curr Top Microbiol Immunol; 2006; 310():199-210. PubMed ID: 16909912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
    Court F; Arnaud P
    Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas.
    Asada K; Abe M; Ushijima T
    J Hum Genet; 2013 Jul; 58(7):428-33. PubMed ID: 23739128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
    Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
    Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
    Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; CaƱadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
    Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
    Teodoridis JM; Hardie C; Brown R
    Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation kinetics and CpG-island methylator phenotype status in colorectal cancer cell lines.
    Wodarz D; Boland CR; Goel A; Komarova NL
    Biol Direct; 2013 Jun; 8():14. PubMed ID: 23758948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island methylator phenotypes in aging and cancer.
    Toyota M; Issa JP
    Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
    Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
    Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype.
    Oue N; Oshimo Y; Nakayama H; Ito R; Yoshida K; Matsusaki K; Yasui W
    Cancer Sci; 2003 Oct; 94(10):901-5. PubMed ID: 14556664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.
    Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M
    Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
    Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Yanokura M; Banno K; Adachi M; Aoki D; Abe K
    Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
    Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
    Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.